D-0172-2025 Class II Ongoing

Recalled by VIONA PHARMACEUTICALS INC — Cranford, NJ

FDA drug recall D-0172-2025 was initiated by VIONA PHARMACEUTICALS INC on Dec 10, 2024 and is designated Class II. Reason for recall: Crystallization The recall status is ongoing. Affected quantity: 2760 packs.

Recall details

Product Type
Drugs
Report Date
Jan 8, 2025
Initiation Date
Dec 10, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2760 packs

Product description

Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-03. packaged in an Airless pump pack

Reason for recall

Crystallization

Distribution pattern

US Nationwide

Code information

Lots T400514, Exp Date 02/2026 & T400808, Exp Date 03/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0172-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0172-2025. Report a data issue: hello@regdatalab.com.